Fatemeh Zarimeidani: Advancing Care for PCOS-Related Infertility
Fatemeh Zarimeidani shared a post on LinkedIn:
“Advancing Care for PCOS‑related Infertility
Polycystic ovarian syndrome (PCOS) is the most common cause of anovulatory infertility.
Letrozole (LE) has emerged as the first‑line ovulation induction therapy for PCOS, offering higher ovulation and live birth rates with a lower risk of multiple gestations compared to clomiphene citrate.
Our team recently conducted a single‑center, parallel randomized clinical trial comparing two LE regimens in treatment‑resistant PCOS patients:
- 7‑day treatment (Group A)
- 10‑day treatment (Group B)
Primary outcomes ovulation rates and follicle measurements
Secondary outcomes pregnancy rates and safety profiles
Key takeaway:
Both regimens were safe and effective, with no significant difference in ovulation or pregnancy rates, though we observed a trend worth exploring further.
Why it matters:
This is the first study to directly compare 7‑day vs. 10‑day Letrozole protocols. While larger trials are needed to confirm the benefits of extended therapy, these findings can help clinicians refine treatment plans for anovulatory PCOS patients who are resistant to standard protocols.
As this reflects my first experience working on clinical trial articles, I would love to hear your kind thoughts on the methodology and how you think it could be enhanced.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Mar 21, 2026, 15:00Samantha Butts Shares Personal and Professional Insights in ASRM Close Up
-
Mar 21, 2026, 14:47Scammers Are Targeting ESHRE2026 Attendees – ESHRE
-
Mar 21, 2026, 14:26No Obvious Harm From Prolonged Oocyte Cryostorage – RBMO
-
Mar 21, 2026, 14:13Empowering Change: Health Systems at the Forefront of Ending FGM/C! – FIGO
-
Mar 21, 2026, 09:56Expanded Carrier Screening: Clinical, Ethical, and Psychosocial Perspectives from Ghent – ESHRE
-
Mar 21, 2026, 09:53Impact of Male Obesity on Embryo Development and Miscarriage Risk – Fertility and Sterility
-
Mar 20, 2026, 17:06Christopher Robinson: AJOG Expert Review on Placenta Accreta After Cesarean
-
Mar 20, 2026, 16:53HCG Failure and Trigger Strategies in IVF – Fertility Plus
-
Mar 20, 2026, 16:38Secure Your Early Bird Ticket for RCOG Annual Professional Development Conference – RCOG